Area of research
Hematology · Molecular Biology
Research interest
Research interests include Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Ovarian cancer diagnosis and treatment, and Acute Myeloid Leukemia Research.
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study
A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia
First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors
PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation
PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer
Mutant p53 expression in fallopian tube epithelium drives cell migration
Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells
Response to Aflibercept After Frequent Re-treatment With Bevacizumab or Ranibizumab in Eyes With Neovascular AMD
Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathway
Gonadotropins Activate Oncogenic Pathways to Enhance Proliferation in Normal Mouse Ovarian Surface Epithelium